NDA 50687, held by Sankyo. Cefpodoxime Proxetil.
As of Nov 16, 2026, NDA 50687 (Banan), held by Sankyo, was first approved by FDA on Aug 7, 1992, with 12 approved supplements and 0 published complete response letters.
| Feb 10, 2000 | Supplement 11Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 10Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 7Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 4Efficacy (new indication or use) · Standard review | Approved | |
| Dec 22, 1997 | Supplement 1Efficacy (new indication or use) · Standard review | Approved | None posted |
| Aug 7, 1992 | Original applicationNew dosage form · Standard review | Approved | None posted |
| BananEQ 100MG BASE · tablet;oral | Cefpodoxime Proxetil | Discontinued |
| BananEQ 200MG BASE · tablet;oral | Cefpodoxime Proxetil | Discontinued |
| Feb 10, 2000 | Supplement 12Labeling · Standard review | Approved | |
| Feb 10, 2000 | Supplement 11Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 10Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 9Labeling · Standard review | Approved | |
| Feb 10, 2000 | Supplement 8Labeling · Standard review | Approved | |
| Feb 10, 2000 | Supplement 7Efficacy (new indication or use) · Standard review | Approved | |
| Feb 10, 2000 | Supplement 4Efficacy (new indication or use) · Standard review | Approved | |
| May 27, 1999 | Supplement 5Labeling · Standard review | Approved | None posted |
| May 25, 1999 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Dec 22, 1997 | Supplement 1Efficacy (new indication or use) · Standard review | Approved | None posted |
| Oct 12, 1993 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 8, 1993 | Supplement 3Labeling · Standard review | Approved | None posted |
| Aug 7, 1992 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters